Within Major Pharmaceutical Preparations industry 278 other companies have achieved higher Quick Ratio than Catalent Inc in first quarter 2025. While Quick Ratio total ranking has improved so far during the Q1 2025 to 1857, from total ranking in the first quarter 2024 at 2124.

Explain Quick Ratio?
How much Cash & cash equivalents CTLT�s has?
What are CTLT�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

CTLT Quick Ratio	(Jun 30 2025) Q1	(Sep 30 2024) Q4	(Jun 30 2024) Q3	(Mar 31 2024) Q2	(Dec 31 2023) Q1
Y / Y Current Liabilities Change	-37.64 %	-34.94 %	-45.89 %	-32.28 %	-33.25 %
Y / Y Cash & cash equivalent Change	-	60.29 %	3.21 %	-35.71 %	-51.28 %
Quick Ratio MRQ	-	0.34	0.48	0.16	0.22
CTLT's Total Ranking	# 1857	# 2124	#	#	#
Seq. Current Liabilities Change	-35.27 %	64.69 %	-39.82 %	-2.8 %	-32.46 %
Seq. Cash & cash equivalent Change	-	15.92 %	78.4 %	-29.26 %	9.57 %

Quick Ratio first quarter 2025 Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 279
Healthcare Sector	# 549
Overall Market	# 1857

Quick Ratio Statistics
High	Average	Low
1.84	0.53	0.14
(Sep 30 2021)		(Sep 30 2023)

Financial Statements
Catalent Inc 's Current Liabilities	$ 646 Millions	Visit CTLT's Balance sheet
Catalent Inc 's Cash & cash equivalent	$ 0 Millions	Visit CTLT's Balance sheet
Source of CTLT's Sales		Visit CTLT's Sales by Geography

Cumulative Catalent Inc 's Quick Ratio

CTLT's Quick Ratio for the trailling 12 Months

CTLT Quick Ratio	(Jun 30 2025) 12 Months	(Sep 30 2024) 12 Months	(Jun 30 2024) 12 Months	(Mar 31 2024) 12 Months	(Dec 31 2023) 12 Months
Y / Y Current Liabilities TTM Growth	-37.09 %	-35.94 %	-18.43 %	-12.29 %	5.35 %
Y / Y Cash & cash equivalent TTM Growth	-18.97 %	-16.18 %	-34 %	-45.17 %	-56.56 %
Quick Ratio TTM	0.24	0.28	0.21	0.19	0.19
Total Ranking TTM	# 3465	# 3605	#	#	#
Seq. Current Liabilities TTM Growth	-10.69 %	-12.81 %	-10.94 %	-9.27 %	-9.06 %
Seq. Cash & cash equivalent TTM Growth	-22.56 %	14.17 %	1.02 %	-9.28 %	-19.9 %

Quick ratio ranking by company, industry and sector >> Back to CTLT Financial Strength Comparisons >> Go to Compare CTLT Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in CTLT's Current Liabilities to $646.00 millions, cumulative Quick Ratio to 0.24 below the CTLT average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 442 other companies have achieved higher Quick Ratio than Catalent Inc . While Quick Ratio overall ranking has improved so far to 3465, from total ranking during the twelve months ending first quarter 2024 at 3605.

Explain Quick Ratio?
How much Cash & cash equivalents CTLT�s has?
What are CTLT�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Major Pharmaceutical Preparations Industry	# 443
Healthcare Sector	# 933
Within the Market	# 3465

trailing twelve months Quick Ratio Statistics
High	Average	Low
1.11	0.58	0.17
(Dec 31 2021)		(Mar 31 2024)

Companies with similar Quick Ratio in the quarter ending Jun 30 2025, within Major Pharmaceutical Preparations Industry

Quick Ratio

Jun 30 2025 MRQ Cash & cash equivalent

Jun 30 2025 MRQ Current Liabilities

Date modified: 2026-09-26T06:52:08+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.